VACCINATION AGAINST COVID 19 INFECTION DURING PREGNANCY AND LACTATION: A BRIEF REVIEW

Objective: Vaccination plays a crucial role in the protection against the Covid 19 infection. However, pregnant and lactating women are excluded from clinical trials of vaccines due to the unknown effects of the vaccine on the expectant mother, fetus, and infant. Pregnancy and the following lactation periods are long processes with unique physiological, psychological, and pathological characteristics, in which many practices are discussed for the mother and the baby. Based on the limited data available on the mechanisms of action of vaccine types, Covid 19 vaccines cannot possibly cause any risk to pregnant women and nursing mothers. On the other hand, there is currently insufficient data on the safety of Covid 19 vaccines in pregnant and lactating women. Result and Discussion: Evidence-based and personalized information about vaccines is needed to support pregnant and breastfeeding women's decision-making about vaccines. Vaccination should be recommended to all pregnant and lactating women after they have been sufficiently informed about the advantage and risks of Covid 19 vaccines and their consent has been obtained. This brief review was conducted to discuss vaccination against Covid 19 infection during pregnancy and the lactation period based on scientific data and literature.

[1]  M. Sezerol,et al.  COVID-19 Vaccine Hesitancy and Related Factors among Unvaccinated Pregnant Women during the Pandemic Period in Turkey , 2023, Vaccines.

[2]  S. Rasmussen,et al.  Covid-19 vaccination in pregnancy , 2022, BMJ.

[3]  E. Tommelein,et al.  The Effects of COVID-19 Vaccination on Lactating Women: A Systematic Review of the Literature , 2022, Frontiers in Immunology.

[4]  H. Gjessing,et al.  Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes. , 2022, JAMA.

[5]  C. Chiamulera,et al.  COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety , 2021, Drug Safety.

[6]  Syed Faraz Ahmed,et al.  The impact of COVID‐19 on pregnancy and therapeutic drug development , 2021, British journal of pharmacology.

[7]  C. Olson,et al.  Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons , 2021, The New England journal of medicine.

[8]  E. Olsen,et al.  Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[9]  M. Demirağ,et al.  [Evaluation of Patients Diagnosed with COVID-19 in Terms of Risk Factors]. , 2020, Mikrobiyoloji bulteni.

[10]  Banu Karaca.  Erişkin Yaş Grubunda COVID-19 Klinik Bulguları , 2020 .

[11]  T. Leung,et al.  ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[12]  S. Rasmussen,et al.  Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know , 2020, American Journal of Obstetrics and Gynecology.

[13]  P. van Damme,et al.  Vaccination during pregnancy: current and possible future recommendations , 2020, European Journal of Pediatrics.

[14]  M. Georgieff,et al.  Breastfeeding and the Use of Human Milk. , 2014, Nursing for women's health.

[15]  T. Ng,et al.  Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome , 2004, American Journal of Obstetrics and Gynecology.